Pyridothiadiazines as potent inhibitors of glucose-induced insulin release.
Lebrun
P
P
Laboratory of Pharmacology, Free University of Brussels, School of Medicine, Belgium.
Antoine
M H
MH
Ouedraogo
R
R
Herchuelz
A
A
de Tullio
P
P
Delarge
J
J
Pirotte
B
B
D000818:Animals; D002118:Calcium / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D003981:Diazoxide / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology*; D006146:Guanidines / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D020110:Pinacidil; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D012413:Rubidium / Q000378:metabolism; D013329:Structure-Activity Relationship; D013829:Thiadiazines / Q000494:pharmacology*; D013997:Time Factors
C099141:BPDZ 62; D006146:Guanidines; D007328:Insulin; D011725:Pyridines; D013829:Thiadiazines; C087201:BPDZ 44; D020110:Pinacidil; D005947:Glucose; D012413:Rubidium; D003981:Diazoxide; D002118:Calcium